Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NWH-UN.TO Stock Summary
Top 10 Correlated ETFs
NWH-UN.TO
In the News
NWH-UN.TO Financial details
Company Rating
Strong Buy
Market Cap
1.09B
Income
-338.04M
Revenue
502.56M
Book val./share
8.67
Cash/share
0.28
Dividend
0.66
Dividend %
14.64%
Employees
213
Optionable
No
Shortable
Yes
Earnings
08 Nov 2023
P/E
-3.26
Forward P/E
-
PEG
0.22
P/S
2.19
P/B
0.52
P/C
15.93
P/FCF
7.94
Quick Ratio
0.13
Current Ratio
0.4
Debt / Equity
1.88
LT Debt / Equity
1.04
-
-
EPS (TTM)
-1.39
EPS next Y
-
EPS next Q
-
EPS this Y
-80.95%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.77%
Revenue last 5Y
5.12%
Revenue Q/Q
-3.42%
EPS Q/Q
153.85%
-
-
-
-
SMA20
-
SMA50
-42.86%
SMA100
-33.33%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-15%
ROC
0.05%
Gross Margin
73%
Oper. Margin
73%
Profit Margin
-67%
Payout
-50%
Shs Outstand
243.17M
Shs Float
221.84M
-
-
-
-
Target Price
-
52W Range
3.89-10.53
52W High
-55.4%
52W Low
+48.67%
RSI
48
Rel Volume
0.41
Avg Volume
1.35M
Volume
549.43K
Perf Week
0.9%
Perf Month
3.24%
Perf Quarter
-42.75%
Perf Half Y
-42.15%
-
-
-
-
Beta
0.979
-
-
Volatility
0.03%, 0.21%
Prev Close
-1.55%
Price
4.46
Change
-1.55%
NWH-UN.TO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.38 | 2.38 | 2.12 | 1.67 | 1.87 | |
Net income per share | 0.63 | 0.48 | 1.79 | 2.73 | 0.52 | |
Operating cash flow per share | 0.9 | 0.75 | 1.07 | 0.56 | 0.93 | |
Free cash flow per share | 0.9 | 0.75 | 1.07 | 0.56 | 0.93 | |
Cash per share | 0.44 | 1.25 | 0.82 | 0.28 | 0.37 | |
Book value per share | 9.15 | 8.59 | 9.31 | 10.67 | 10.21 | |
Tangible book value per share | 15 | 12.94 | 13.9 | 15.32 | 15.2 | |
Share holders equity per share | 9.15 | 8.59 | 9.31 | 10.67 | 10.21 | |
Interest debt per share | 28.52 | 18.64 | 16.43 | 13.59 | 15.98 | |
Market cap | 981.85M | 1.83B | 2.22B | 3.1B | 2.29B | |
Enterprise value | 3.75B | 4.37B | 4.86B | 5.98B | 5.88B | |
P/E ratio | 14.94 | 25.02 | 7.05 | 5.06 | 18.2 | |
Price to sales ratio | 2.81 | 5.01 | 5.93 | 8.26 | 5.09 | |
POCF ratio | 10.52 | 15.82 | 11.75 | 24.77 | 10.2 | |
PFCF ratio | 10.57 | 15.88 | 11.76 | 24.86 | 10.23 | |
P/B Ratio | 1.04 | 1.39 | 1.35 | 1.29 | 0.93 | |
PTB ratio | 1.04 | 1.39 | 1.35 | 1.29 | 0.93 | |
EV to sales | 10.72 | 11.95 | 13 | 15.95 | 13.1 | |
Enterprise value over EBITDA | 13.23 | 29.82 | 12.34 | 16.68 | 16.34 | |
EV to operating cash flow | 40.15 | 37.76 | 25.75 | 47.83 | 26.23 | |
EV to free cash flow | 40.33 | 37.88 | 25.79 | 48.01 | 26.3 | |
Earnings yield | 0.07 | 0.04 | 0.14 | 0.2 | 0.05 | |
Free cash flow yield | 0.09 | 0.06 | 0.09 | 0.04 | 0.1 | |
Debt to equity | 2.97 | 2.07 | 1.7 | 1.23 | 1.5 | |
Debt to assets | 0.55 | 0.49 | 0.48 | 0.42 | 0.43 | |
Net debt to EBITDA | 9.76 | 17.32 | 6.71 | 8.04 | 9.99 | |
Current ratio | 0.32 | 1.39 | 0.32 | 0.19 | 1.01 | |
Interest coverage | 1.97 | 1.11 | 3.8 | 3.49 | 2.19 | |
Income quality | 0.46 | 0.72 | 0.48 | 0.2 | 1.78 | |
Dividend Yield | 0.09 | 0.05 | 0.06 | 0.04 | 0.07 | |
Payout ratio | 1.34 | 1.37 | 0.42 | 0.23 | 1.24 | |
Sales general and administrative to revenue | 0.08 | 0.09 | 0.08 | 0.11 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0.03 | 0.01 | |
Intangibles to total assets | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.32 | -0.19 | -0.15 | -0.35 | -0.44 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | |
Graham number | 11.43 | 9.6 | 19.34 | 25.6 | 10.95 | |
ROIC | 0.05 | 0.02 | 0.09 | 0.06 | 0.04 | |
Return on tangible assets | 0.01 | 0.01 | 0.05 | 0.09 | 0.01 | |
Graham Net | -31.87 | -20.63 | -17.85 | -15.27 | -19.34 | |
Working capital | -226.4M | 102.52M | -390.26M | -608.92M | 14.38M | |
Tangible asset value | 1.55B | 1.99B | 2.45B | 3.43B | 3.66B | |
Net current asset value | -3.28B | -3.09B | -3.13B | -3.4B | -3.66B | |
Invested capital | 2.97 | 2.07 | 1.7 | 1.23 | 1.5 | |
Average receivables | 75.92M | 53.82M | 43.27M | 52.46M | 56.12M | |
Average payables | 66.22M | 83.67M | 92.4M | 91.15M | 111.64M | |
Average inventory | 86.65M | 58.52M | 55.67M | 0 | 0 | |
Days sales outstanding | 54.87 | 54.92 | 30.72 | 71.57 | 31.54 | |
Days payables outstanding | 343.4 | 444.53 | 441.4 | 479.03 | 484.26 | |
Days of inventory on hand | 26.17 | 535.27 | 0 | 0 | 0 | |
Receivables turnover | 6.65 | 6.65 | 11.88 | 5.1 | 11.57 | |
Payables turnover | 1.06 | 0.82 | 0.83 | 0.76 | 0.75 | |
Inventory turnover | 13.95 | 0.68 | 0 | 0 | 0 | |
ROE | 0.07 | 0.06 | 0.19 | 0.26 | 0.05 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.48 | 0.49 | 0.56 | 0.52 | 0.5 | |
Net income per share | 0.09 | -0.56 | -0.37 | -0.13 | -0.33 | |
Operating cash flow per share | 0.28 | 0.23 | 0.09 | 0.15 | 0.11 | |
Free cash flow per share | 0.28 | 0.23 | 0.09 | 0.15 | 0.11 | |
Cash per share | 0.3 | 0.37 | 0.32 | 0.28 | 0.28 | |
Book value per share | 10.37 | 10.21 | 9.68 | 9.22 | 8.67 | |
Tangible book value per share | 15.25 | 15.2 | 14.58 | 13.59 | 12.94 | |
Share holders equity per share | 10.37 | 10.21 | 9.68 | 9.22 | 8.67 | |
Interest debt per share | 14.68 | 15.51 | 15.41 | 16.71 | 16.57 | |
Market cap | 2.54B | 2.29B | 2.05B | 1.53B | 1.24B | |
Enterprise value | 5.95B | 5.88B | 5.64B | 5.46B | 5.14B | |
P/E ratio | 30.14 | -4.22 | -5.74 | -11.89 | -3.8 | |
Price to sales ratio | 21.95 | 19.29 | 15.12 | 12.06 | 10.11 | |
POCF ratio | 38.33 | 41.71 | 96.67 | 41.57 | 47.26 | |
PFCF ratio | 38.39 | 41.79 | 96.86 | 41.61 | 47.27 | |
P/B Ratio | 1.02 | 0.93 | 0.87 | 0.68 | 0.59 | |
PTB ratio | 1.02 | 0.93 | 0.87 | 0.68 | 0.59 | |
EV to sales | 51.35 | 49.6 | 41.65 | 43.16 | 42.05 | |
Enterprise value over EBITDA | 74.76 | 69.93 | 52.94 | 77.14 | 48.22 | |
EV to operating cash flow | 89.68 | 107.25 | 266.22 | 148.75 | 196.52 | |
EV to free cash flow | 89.81 | 107.45 | 266.75 | 148.9 | 196.58 | |
Earnings yield | 0.01 | -0.06 | -0.04 | -0.02 | -0.07 | |
Free cash flow yield | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | |
Debt to equity | 1.4 | 1.5 | 1.57 | 1.79 | 1.88 | |
Debt to assets | 0.42 | 0.43 | 0.44 | 0.5 | 0.51 | |
Net debt to EBITDA | 42.81 | 42.73 | 33.72 | 55.58 | 36.63 | |
Current ratio | 3.15 | 1.01 | 0.93 | 0.42 | 0.4 | |
Interest coverage | 1.85 | 1.58 | 1.87 | 1.22 | 1.78 | |
Income quality | 3.14 | -0.4 | -0.24 | -0.34 | -0.27 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | |
Payout ratio | 1.88 | -0.29 | -0.44 | -1.23 | -0.6 | |
Sales general and administrative to revenue | 0.11 | 0.1 | 0.1 | 0.12 | 0.14 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.32 | -0.29 | -0.13 | -0.14 | -0.02 | |
Stock based compensation to revenue | 0.02 | 0.04 | 0.02 | 0.02 | 0.02 | |
Graham number | 4.53 | 11.37 | 8.97 | 5.23 | 8.08 | |
ROIC | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Return on tangible assets | 0 | -0.02 | -0.01 | 0 | -0.01 | |
Graham Net | -18.55 | -19.34 | -19.43 | -18.86 | -18.52 | |
Working capital | 1.27B | 14.38M | -82.56M | -467.16M | -510.69M | |
Tangible asset value | 3.66B | 3.66B | 3.52B | 3.3B | 3.15B | |
Net current asset value | -2.69B | -3.66B | -3.67B | -4.35B | -4.27B | |
Invested capital | 1.4 | 1.5 | 1.57 | 1.79 | 1.88 | |
Average receivables | 48.39M | 40.31M | 47.52M | 47.34M | 42.47M | |
Average payables | 93.32M | 118.68M | 132.37M | 128.68M | 129.97M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 32.51 | 29.45 | 37.41 | 27.34 | 34.27 | |
Days payables outstanding | 307.72 | 316.2 | 296.43 | 357.21 | 445.26 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.77 | 3.06 | 2.41 | 3.29 | 2.63 | |
Payables turnover | 0.29 | 0.28 | 0.3 | 0.25 | 0.2 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.01 | -0.06 | -0.04 | -0.01 | -0.04 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
NWH-UN.TO Frequently Asked Questions
What is NorthWest Healthcare Properties Real Estate Investment Trust stock symbol ?
NorthWest Healthcare Properties Real Estate Investment Trust is a CA stock , located in Toronto of On and trading under the symbol NWH-UN.TO
What is NorthWest Healthcare Properties Real Estate Investment Trust stock quote today ?
NorthWest Healthcare Properties Real Estate Investment Trust stock price is $4.46 today.
Is NorthWest Healthcare Properties Real Estate Investment Trust stock public?
Yes, NorthWest Healthcare Properties Real Estate Investment Trust is a publicly traded company.